| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALB
|
albumin
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ANGPT4
|
angiopoietin 4
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
AQP10
|
aquaporin 10
|
|
ARSA
|
arylsulfatase A
|
|
ASIP
|
agouti signaling protein
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
BBS12
|
Bardet-Biedl syndrome 12
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
C1QTNF3
|
C1q and tumor necrosis factor related protein 3
|
|
C5AR2
|
complement component 5a receptor 2
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCDC80
|
coiled-coil domain containing 80
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CD34
|
CD34 molecule
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CIDEA
|
cell death-inducing DFFA-like effector a
|
|
CIDEC
|
cell death-inducing DFFA-like effector c
|
|
CLTCL1
|
clathrin, heavy chain-like 1
|
|
CPPED1
|
calcineurin-like phosphoesterase domain containing 1
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CRH
|
corticotropin releasing hormone
|
|
CTF1
|
cardiotrophin 1
|
|
CTGF
|
connective tissue growth factor
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDT
|
D-dopachrome tautomerase
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DENND4C
|
DENN/MADD domain containing 4C
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DRD2
|
dopamine receptor D2
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPO
|
erythropoietin
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FGF21
|
fibroblast growth factor 21
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOSL2
|
FOS-like antigen 2
|
|
FOXA2
|
forkhead box A2
|
|
FTO
|
fat mass and obesity associated
|
|
GDF15
|
growth differentiation factor 15
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GLUL
|
glutamate-ammonia ligase
|
|
HDAC5
|
histone deacetylase 5
|
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL11
|
interleukin 11
|
|
IL12B
|
interleukin 12B
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL33
|
interleukin 33
|
|
IL6
|
interleukin 6
|
|
INHBB
|
inhibin, beta B
|
|
INS
|
insulin
|
|
INSIG1
|
insulin induced gene 1
|
|
INSR
|
insulin receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
JAK3
|
Janus kinase 3
|
|
KCTD13
|
potassium channel tetramerization domain containing 13
|
|
KLF11
|
Kruppel-like factor 11
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LMNA
|
lamin A/C
|
|
LPL
|
lipoprotein lipase
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRPAP1
|
low density lipoprotein receptor-related protein associated protein 1
|
|
LYRM1
|
LYR motif containing 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis
|
|
MGLL
|
monoglyceride lipase
|
|
MIR132
|
microRNA 132
|
|
MIR145
|
microRNA 145
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR221
|
microRNA 221
|
|
MIR637
|
microRNA 637
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MT3
|
metallothionein 3
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NPPA
|
natriuretic peptide A
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
OSM
|
oncostatin M
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDK4
|
pyruvate dehydrogenase kinase, isozyme 4
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PID1
|
phosphotyrosine interaction domain containing 1
|
|
PLIN1
|
perilipin 1
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRDM16
|
PR domain containing 16
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PSMB1
|
proteasome (prosome, macropain) subunit, beta type, 1
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTPRQ
|
protein tyrosine phosphatase, receptor type, Q
|
|
PTRF
|
polymerase I and transcript release factor
|
|
PTX3
|
pentraxin 3, long
|
|
RAB10
|
RAB10, member RAS oncogene family
|
|
RALGAPA2
|
Ral GTPase activating protein, alpha subunit 2 (catalytic)
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RETN
|
resistin
|
|
RETSAT
|
retinol saturase (all-trans-retinol 13,14-reductase)
|
|
RHOA
|
ras homolog family member A
|
|
SAA1
|
serum amyloid A1
|
|
SAA2
|
serum amyloid A2
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SIK2
|
salt-inducible kinase 2
|
|
SIK3
|
SIK family kinase 3
|
|
SIRT1
|
sirtuin 1
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC16A7
|
solute carrier family 16 (monocarboxylate transporter), member 7
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
STC1
|
stanniocalcin 1
|
|
STEAP4
|
STEAP family member 4
|
|
STK11
|
serine/threonine kinase 11
|
|
TAC1
|
tachykinin, precursor 1
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBS1
|
thrombospondin 1
|
|
THRAP3
|
thyroid hormone receptor associated protein 3
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UCN2
|
urocortin 2
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZNF395
|
zinc finger protein 395
|
